Calcineurin Inhibitor Immunosuppressant [EPC]

Calcineurin Inhibitor Immunosuppressant [EPC] was reported 130452 times

These side effects are most commonly reported by patients taking drugs of the Calcineurin Inhibitor Immunosuppressant [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 15318
1 EYE IRRITATION 10627
2 OFF LABEL USE 10421
3 EYE PAIN 4936
4 HEADACHE 4814
5 NAUSEA 4592
6 PRODUCT USE IN UNAPPROVED INDICATION 4531
7 DIARRHOEA 4422
8 PYREXIA 4327
9 FATIGUE 4278
10 PAIN 3607
11 PNEUMONIA 3596
12 CONDITION AGGRAVATED 3582
13 VISION BLURRED 3510
14 HYPERTENSION 3297
15 RASH 3204
16 PRURITUS 3068
17 OCULAR HYPERAEMIA 3060
18 ARTHRALGIA 2873
19 DYSPNOEA 2868
20 VOMITING 2780
21 DRY EYE 2589
22 DEATH 2566
23 RENAL IMPAIRMENT 2475
24 BLOOD CREATININE INCREASED 2357
25 CYTOMEGALOVIRUS INFECTION 2332
26 MALAISE 2232
27 PRODUCT USE ISSUE 2232
28 SEPSIS 2228
29 INFECTION 2221
30 DIZZINESS 2212
31 PRODUCT DOSE OMISSION ISSUE 2149
32 PAIN IN EXTREMITY 2034
33 ANAEMIA 2027
34 ASTHENIA 1988
35 DRUG INTOLERANCE 1979
36 ACUTE KIDNEY INJURY 1977
37 TREATMENT FAILURE 1966
38 DRUG INTERACTION 1956
39 RENAL FAILURE 1952
40 LACRIMATION INCREASED 1872
41 HYPERSENSITIVITY 1868
42 COUGH 1861
43 ERYTHEMA 1843
44 PSORIASIS 1826
45 DRUG HYPERSENSITIVITY 1805
46 EYE PRURITUS 1755
47 GRAFT VERSUS HOST DISEASE 1744
48 ALOPECIA 1734
49 URTICARIA 1698
50 WEIGHT DECREASED 1665
51 ABDOMINAL PAIN 1657
52 URINARY TRACT INFECTION 1647
53 BLOOD PRESSURE INCREASED 1629
54 THROMBOCYTOPENIA 1550
55 INCORRECT DOSE ADMINISTERED 1533
56 FALL 1529
57 COVID-19 1500
58 INSOMNIA 1498
59 RHEUMATOID ARTHRITIS 1478
60 PERIPHERAL SWELLING 1406
61 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1401
62 NEUTROPENIA 1381
63 PANCYTOPENIA 1349
64 TRANSPLANT REJECTION 1311
65 PLATELET COUNT DECREASED 1309
66 THERAPY INTERRUPTED 1309
67 ACUTE GRAFT VERSUS HOST DISEASE 1306
68 NASOPHARYNGITIS 1291
69 BACK PAIN 1289
70 RESPIRATORY FAILURE 1264
71 ABDOMINAL DISCOMFORT 1255
72 JOINT SWELLING 1248
73 DISEASE PROGRESSION 1226
74 VISUAL IMPAIRMENT 1226
75 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1216
76 CHRONIC GRAFT VERSUS HOST DISEASE 1214
77 WEIGHT INCREASED 1196
78 FOREIGN BODY SENSATION IN EYES 1184
79 FEBRILE NEUTROPENIA 1176
80 HAEMOGLOBIN DECREASED 1163
81 DECREASED APPETITE 1139
82 SEPTIC SHOCK 1125
83 CYTOMEGALOVIRUS INFECTION REACTIVATION 1116
84 ABDOMINAL PAIN UPPER 1111
85 THERAPY NON-RESPONDER 1109
86 MYALGIA 1104
87 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1095
88 ALANINE AMINOTRANSFERASE INCREASED 1083
89 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1080
90 PROTEINURIA 1079
91 THROMBOTIC MICROANGIOPATHY 1078
92 FEELING ABNORMAL 1069
93 NEPHROPATHY TOXIC 1066
94 ANXIETY 1065
95 MUSCLE SPASMS 1057
96 HERPES ZOSTER 1052
97 EPSTEIN-BARR VIRUS INFECTION 1051
98 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1040
99 C-REACTIVE PROTEIN INCREASED 1033
100 PRODUCT STORAGE ERROR 1016
101 LEUKOPENIA 1013
102 EYE SWELLING 1009
103 THERAPEUTIC RESPONSE DECREASED 995
104 ARTHRITIS 993
105 MUCOSAL INFLAMMATION 991
106 TREMOR 968
107 INFLUENZA 967
108 PRODUCT CONTAINER ISSUE 965
109 CATARACT 962
110 GAIT DISTURBANCE 957
111 SINUSITIS 955
112 HYPOTENSION 951
113 MULTIPLE ORGAN DYSFUNCTION SYNDROME 948
114 ASPARTATE AMINOTRANSFERASE INCREASED 932
115 OEDEMA PERIPHERAL 920
116 CHEST PAIN 916
117 STOMATITIS 910
118 INFLAMMATION 909
119 CONSTIPATION 895
120 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 894
121 OCULAR DISCOMFORT 890
122 DISEASE RECURRENCE 873
123 EYE DISCHARGE 867
124 DEPRESSION 861
125 HEPATIC FUNCTION ABNORMAL 855
126 BK VIRUS INFECTION 848
127 HEPATIC ENZYME INCREASED 845
128 WHITE BLOOD CELL COUNT DECREASED 845
129 GASTROINTESTINAL DISORDER 839
130 PSORIATIC ARTHROPATHY 837
131 MUSCULOSKELETAL STIFFNESS 820
132 KIDNEY TRANSPLANT REJECTION 818
133 GENERAL PHYSICAL HEALTH DETERIORATION 817
134 CONTRAINDICATED PRODUCT ADMINISTERED 810
135 RENAL FAILURE ACUTE 809
136 ACCIDENTAL EXPOSURE TO PRODUCT 807
137 MUSCULAR WEAKNESS 803
138 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 790
139 TOXICITY TO VARIOUS AGENTS 786
140 DIABETES MELLITUS 782
141 THERAPEUTIC PRODUCT EFFECT DECREASED 777
142 CHILLS 771
143 CONFUSIONAL STATE 758
144 ILLNESS 758
145 HYPOAESTHESIA 750
146 INFUSION RELATED REACTION 745
147 MULTIPLE USE OF SINGLE-USE PRODUCT 743
148 PHOTOPHOBIA 742
149 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 737
150 DEHYDRATION 735
151 SOMNOLENCE 726
152 PLEURAL EFFUSION 725
153 DRUG DOSE OMISSION 719
154 PRODUCT DOSE OMISSION 718
155 MIGRAINE 714
156 OEDEMA 714
157 PARAESTHESIA 714
158 FUNGAL INFECTION 696
159 SWELLING 696
160 CYTOMEGALOVIRUS VIRAEMIA 690
161 RHABDOMYOLYSIS 686
162 ARTHROPATHY 685
163 INTERSTITIAL LUNG DISEASE 684
164 STAPHYLOCOCCAL INFECTION 680
165 BURNING SENSATION 677
166 SYNOVITIS 675
167 OROPHARYNGEAL PAIN 672
168 EPISTAXIS 661
169 INTENTIONAL PRODUCT USE ISSUE 659
170 DRY SKIN 658
171 BLOOD BILIRUBIN INCREASED 653
172 ACNE 652
173 BACTERIAL INFECTION 651
174 INJECTION SITE PAIN 650
175 RENAL DISORDER 648
176 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 639
177 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 636
178 APLASTIC ANAEMIA 620
179 CELLULITIS 620
180 SKIN EXFOLIATION 618
181 DRUG ERUPTION 617
182 DYSPHAGIA 617
183 BRONCHITIS 616
184 RASH PRURITIC 614
185 BASAL CELL CARCINOMA 611
186 CHRONIC KIDNEY DISEASE 611
187 MULTI-ORGAN FAILURE 604
188 BRONCHOPULMONARY ASPERGILLOSIS 602
189 CYSTITIS HAEMORRHAGIC 598
190 THERAPY CESSATION 598
191 CONTUSION 595
192 GASTROINTESTINAL HAEMORRHAGE 595
193 HEART RATE INCREASED 595
194 DRUG RESISTANCE 593
195 GRAFT VERSUS HOST DISEASE IN SKIN 592
196 TRANSPLANT DYSFUNCTION 591
197 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 589
198 SKIN LESION 581
199 RHINORRHOEA 577
200 ANGIOEDEMA 576
201 CARDIAC FAILURE 576
202 LUNG DISORDER 569
203 LIVER FUNCTION TEST ABNORMAL 564
204 EYE DISORDER 563
205 MATERNAL EXPOSURE DURING PREGNANCY 558
206 ATRIAL FIBRILLATION 555
207 MEMORY IMPAIRMENT 555
208 SKIN ULCER 555
209 SYSTEMIC LUPUS ERYTHEMATOSUS 550
210 ANAPHYLACTIC REACTION 540
211 NEUROPATHY PERIPHERAL 540
212 ABDOMINAL DISTENSION 537
213 DRY MOUTH 537
214 ADENOVIRUS INFECTION 536
215 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 526
216 LOSS OF CONSCIOUSNESS 526
217 GLOMERULAR FILTRATION RATE DECREASED 523
218 DYSPEPSIA 522
219 MYOCARDIAL INFARCTION 518
220 SWELLING FACE 518
221 LYMPHADENOPATHY 517
222 PSEUDOMONAS INFECTION 516
223 MOBILITY DECREASED 515
224 VIRAL INFECTION 511
225 ADVERSE DRUG REACTION 507
226 STRESS 506
227 SEIZURE 501
228 ADVERSE EVENT 499
229 DERMATITIS ATOPIC 499
230 RED BLOOD CELL SEDIMENTATION RATE INCREASED 498
231 LIVER DISORDER 492
232 HAEMORRHAGE 490
233 CEREBROVASCULAR ACCIDENT 486
234 UPPER RESPIRATORY TRACT INFECTION 484
235 OVARIAN CYST 481
236 TACHYCARDIA 481
237 CONVULSION 474
238 NECK PAIN 474
239 BONE MARROW FAILURE 472
240 OSTEOPOROSIS 472
241 OVERDOSE 470
242 BLOOD LACTATE DEHYDROGENASE INCREASED 469
243 ASTHMA 468
244 HAEMATURIA 464
245 BACTERAEMIA 454
246 PRODUCT QUALITY ISSUE 451
247 SLEEP DISORDER 451
248 VISUAL ACUITY REDUCED 451
249 ECZEMA 449
250 PALPITATIONS 449
251 VENOOCCLUSIVE LIVER DISEASE 446
252 ACUTE RESPIRATORY DISTRESS SYNDROME 445
253 DISCOMFORT 443
254 PULMONARY EMBOLISM 440
255 HEPATIC FAILURE 438
256 THERAPY PARTIAL RESPONDER 437
257 CHEST DISCOMFORT 435
258 OSTEOARTHRITIS 434
259 EXPIRED PRODUCT ADMINISTERED 433
260 GASTROOESOPHAGEAL REFLUX DISEASE 433
261 BLOOD GLUCOSE INCREASED 432
262 BLOOD CHOLESTEROL INCREASED 431
263 PNEUMOCYSTIS JIROVECII PNEUMONIA 430
264 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 420
265 HYPERCALCAEMIA 418
266 DRUG LEVEL INCREASED 414
267 ASPERGILLUS INFECTION 413
268 NASAL CONGESTION 413
269 BLOOD UREA INCREASED 406
270 HYPERKALAEMIA 405
271 NEUROTOXICITY 404
272 HYPERHIDROSIS 401
273 ULCER 400
274 HOSPITALISATION 399
275 SURGERY 399
276 BLISTER 396
277 HYPOGAMMAGLOBULINAEMIA 390
278 ASCITES 388
279 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 388
280 HEPATOTOXICITY 388
281 NEPHROTIC SYNDROME 388
282 SKIN DISORDER 388
283 HYPOXIA 387
284 RESPIRATORY DISTRESS 384
285 BLOOD ALKALINE PHOSPHATASE INCREASED 383
286 DYSGEUSIA 379
287 BALANCE DISORDER 378
288 TRANSAMINASES INCREASED 378
289 HEPATITIS 375
290 BLOOD PRESSURE DECREASED 374
291 C-REACTIVE PROTEIN ABNORMAL 371
292 PRODUCT DOSE OMISSION IN ERROR 369
293 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 367
294 MUSCULOSKELETAL PAIN 367
295 CARDIAC ARREST 365
296 GAMMA-GLUTAMYLTRANSFERASE INCREASED 359
297 PRODUCTIVE COUGH 356
298 PERICARDIAL EFFUSION 354
299 TREATMENT NONCOMPLIANCE 354
300 CANDIDA INFECTION 352
301 ENCEPHALOPATHY 348
302 LYMPHOPENIA 348
303 THROMBOSIS 348
304 INSTILLATION SITE PAIN 346
305 NEOPLASM MALIGNANT 341
306 CLOSTRIDIUM DIFFICILE COLITIS 340
307 OXYGEN SATURATION DECREASED 340
308 COMPLICATIONS OF TRANSPLANTED KIDNEY 338
309 SKIN NECROSIS 338
310 WHITE BLOOD CELL COUNT INCREASED 338
311 INTENTIONAL PRODUCT MISUSE 337
312 NO ADVERSE EVENT 335
313 CHOLESTASIS 333
314 CYSTITIS 333
315 ENTEROCOCCAL INFECTION 333
316 DEEP VEIN THROMBOSIS 328
317 PULMONARY OEDEMA 327
318 DYSURIA 326
319 DISSEMINATED INTRAVASCULAR COAGULATION 325
320 ERYTHEMA OF EYELID 324
321 OSTEONECROSIS 324
322 SKIN DISCOLOURATION 323
323 DYSPHONIA 322
324 HERPES SIMPLEX 322
325 EYE INFLAMMATION 321
326 CEREBRAL HAEMORRHAGE 320
327 HYPONATRAEMIA 320
328 HOT FLUSH 318
329 MYELOSUPPRESSION 317
330 SYNCOPE 316
331 FOETAL EXPOSURE DURING PREGNANCY 315
332 EYELID OEDEMA 314
333 MOUTH ULCERATION 314
334 EYE INFECTION 311
335 HALLUCINATION 311
336 PANNICULITIS 309
337 SQUAMOUS CELL CARCINOMA 309
338 COLITIS 308
339 RENAL TUBULAR NECROSIS 308
340 BLINDNESS 306
341 TRANSPLANT FAILURE 305
342 ABNORMAL SENSATION IN EYE 303
343 IMPAIRED HEALING 302
344 BLOOD CREATINE PHOSPHOKINASE INCREASED 301
345 DEPRESSED LEVEL OF CONSCIOUSNESS 301
346 FLUID RETENTION 300
347 GLAUCOMA 299
348 CARDIAC FAILURE CONGESTIVE 297
349 PRODUCT USE COMPLAINT 297
350 HAEMODIALYSIS 296
351 PANCREATITIS 296
352 KLEBSIELLA INFECTION 295
353 CARDIAC DISORDER 294
354 SKIN PLAQUE 294
355 ACUTE MYELOID LEUKAEMIA 293
356 JAUNDICE 293
357 RASH ERYTHEMATOUS 292
358 RESPIRATORY TRACT INFECTION 291
359 UNDERDOSE 291
360 EMOTIONAL DISTRESS 290
361 LABORATORY TEST ABNORMAL 290
362 BLOOD PRESSURE SYSTOLIC INCREASED 289
363 DRUG-INDUCED LIVER INJURY 287
364 ILL-DEFINED DISORDER 286
365 PULMONARY FIBROSIS 286
366 THROAT IRRITATION 286
367 PNEUMONIA CYTOMEGALOVIRAL 284
368 AGRANULOCYTOSIS 283
369 INFLUENZA LIKE ILLNESS 283
370 METABOLIC ACIDOSIS 282
371 BLOOD PARATHYROID HORMONE DECREASED 281
372 ESCHERICHIA INFECTION 280
373 GENERALISED OEDEMA 279
374 HAEMATOCHEZIA 276
375 RHEUMATOID NODULE 276
376 VERTIGO 276
377 INJURY 275
378 BONE PAIN 274
379 DERMATITIS 273
380 TUBULOINTERSTITIAL NEPHRITIS 273
381 ACUTE RESPIRATORY FAILURE 272
382 FEELING HOT 272
383 FIBROMYALGIA 271
384 NEUTROPHIL COUNT DECREASED 270
385 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 269
386 DYSPNOEA EXERTIONAL 268
387 PNEUMONIA BACTERIAL 266
388 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 265
389 SWELLING OF EYELID 265
390 DIPLOPIA 264
391 PREMATURE BABY 263
392 HAEMOLYSIS 262
393 VENOOCCLUSIVE DISEASE 262
394 AMNESIA 261
395 WOUND 261
396 PRODUCT PACKAGING QUANTITY ISSUE 260
397 LUNG INFILTRATION 258
398 LOWER RESPIRATORY TRACT INFECTION 257
399 ORAL PAIN 257
400 UNEVALUABLE EVENT 257
401 CYTOPENIA 256
402 MYELODYSPLASTIC SYNDROME 256
403 ORAL HERPES 255
404 FLUSHING 254
405 CLOSTRIDIUM DIFFICILE INFECTION 253
406 HYPERGLYCAEMIA 253
407 LIVER TRANSPLANT REJECTION 253
408 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 253
409 RESPIRATORY DISORDER 253
410 COLITIS ULCERATIVE 251
411 CONJUNCTIVITIS 250
412 MALIGNANT NEOPLASM PROGRESSION 250
413 GINGIVAL HYPERTROPHY 249
414 RED BLOOD CELL COUNT DECREASED 249
415 HUMAN HERPESVIRUS 6 INFECTION 248
416 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 248
417 HYPERBILIRUBINAEMIA 246
418 INJECTION SITE ERYTHEMA 246
419 TINNITUS 245
420 PAIN OF SKIN 244
421 HYPOKALAEMIA 243
422 STAPHYLOCOCCAL SEPSIS 243
423 WHEEZING 243
424 URINE PROTEIN/CREATININE RATIO INCREASED 241
425 PRODUCT ADMINISTRATION ERROR 240
426 SPLENOMEGALY 240
427 END STAGE RENAL DISEASE 239
428 MENTAL DISORDER 239
429 HAEMATOCRIT DECREASED 238
430 LETHARGY 238
431 MYOPATHY 238
432 SPEECH DISORDER 238
433 INCORRECT PRODUCT STORAGE 237
434 SKIN BURNING SENSATION 237
435 ASTHENOPIA 236
436 DEVICE RELATED INFECTION 236
437 FLATULENCE 236
438 LYMPHOPROLIFERATIVE DISORDER 236
439 GRANULOMA SKIN 235
440 SJOGREN^S SYNDROME 235
441 HYPOTHYROIDISM 234
442 ACUTE MYELOID LEUKAEMIA RECURRENT 233
443 HEPATIC CIRRHOSIS 232
444 HISTIOCYTOSIS HAEMATOPHAGIC 232
445 PYELONEPHRITIS 231
446 BRAIN OEDEMA 230
447 PNEUMONITIS 230
448 THERAPEUTIC RESPONSE UNEXPECTED 230
449 ASPERGILLOSIS 229
450 COMA 229
451 EPSTEIN-BARR VIRAEMIA 229
452 LIP SWELLING 228
453 TENDONITIS 228
454 DIFFUSE LARGE B-CELL LYMPHOMA 227
455 STAPHYLOCOCCAL BACTERAEMIA 227
456 INJECTION SITE BRUISING 226
457 APLASIA PURE RED CELL 225
458 SERUM FERRITIN INCREASED 224
459 CEREBRAL INFARCTION 223
460 DRUG EXPOSURE DURING PREGNANCY 222
461 SHOCK 222
462 NERVOUS SYSTEM DISORDER 221
463 TOXIC EPIDERMAL NECROLYSIS 221
464 PRODUCT DELIVERY MECHANISM ISSUE 220
465 SKIN CANCER 219
466 DIVERTICULITIS 218
467 EXPOSURE DURING PREGNANCY 216
468 GASTRITIS 216
469 RASH MACULO-PAPULAR 216
470 SKIN INFECTION 215
471 IMMUNOSUPPRESSION 214
472 RASH MACULAR 213
473 RENAL FAILURE CHRONIC 213
474 ARRHYTHMIA 212
475 EYELID PAIN 212
476 GAIT INABILITY 212
477 BLOOD PRESSURE FLUCTUATION 211
478 LEUKOCYTOSIS 211
479 VIRAL HAEMORRHAGIC CYSTITIS 211
480 DEPRESSED MOOD 210
481 CHOLELITHIASIS 209
482 INSURANCE ISSUE 209
483 CYTOMEGALOVIRUS COLITIS 207
484 HEPATITIS C 207
485 OSTEOMYELITIS 207
486 DYSARTHRIA 206
487 PRODUCT PACKAGING DIFFICULT TO OPEN 206
488 CHRONIC SPONTANEOUS URTICARIA 205
489 GRAFT VERSUS HOST DISEASE IN LIVER 205
490 HAEMOLYTIC ANAEMIA 205
491 POLLAKIURIA 205
492 COGNITIVE DISORDER 204
493 COVID-19 PNEUMONIA 204
494 INJECTION SITE REACTION 204
495 PERITONITIS 204
496 PHOTOSENSITIVITY REACTION 204
497 DISORIENTATION 203
498 GASTRIC DISORDER 203
499 NEPHROLITHIASIS 203
500 PRODUCT DROPPER ISSUE 202
501 DRUG TOLERANCE DECREASED 201
502 HYPOALBUMINAEMIA 201
503 DISTURBANCE IN ATTENTION 200
504 NERVOUSNESS 200
505 OSTEOPENIA 200
506 SUICIDAL IDEATION 199
507 AGITATION 198
508 EAR INFECTION 198
509 LYMPHOMA 198
510 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 198
511 BLOOD POTASSIUM INCREASED 197
512 HAEMORRHAGE INTRACRANIAL 197
513 HEPATIC STEATOSIS 197
514 OBLITERATIVE BRONCHIOLITIS 197
515 JOINT INJURY 196
516 LIVER FUNCTION TEST INCREASED 196
517 PANCREATITIS ACUTE 196
518 ALTERED STATE OF CONSCIOUSNESS 195
519 ANURIA 195
520 CUSHINGOID 195
521 GASTROENTERITIS 195
522 LIVER INJURY 195
523 ABSCESS 194
524 PNEUMONIA FUNGAL 194
525 PRODUCT PRESCRIBING ISSUE 194
526 REBOUND EFFECT 194
527 GOUT 192
528 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 192
529 NIGHT SWEATS 192
530 APHASIA 191
531 BACTERIAL SEPSIS 191
532 CROHN^S DISEASE 191
533 DEAFNESS 191
534 SQUAMOUS CELL CARCINOMA OF SKIN 191
535 LIMB DISCOMFORT 190
536 SNEEZING 189
537 DIALYSIS 188
538 LOCALISED INFECTION 187
539 LUNG INFECTION 187
540 PULMONARY HYPERTENSION 187
541 HAEMOPTYSIS 186
542 PYODERMA GANGRENOSUM 186
543 URINE OUTPUT DECREASED 186
544 BRADYCARDIA 185
545 EMOTIONAL DISORDER 185
546 EYELID IRRITATION 185
547 PLATELET COUNT INCREASED 185
548 PRODUCT PRESCRIBING ERROR 185
549 TENDERNESS 185
550 UVEITIS 185
551 INJECTION SITE SWELLING 183
552 SKIN FISSURES 183
553 HEART TRANSPLANT REJECTION 182
554 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 181
555 MALIGNANT MELANOMA 181
556 POST PROCEDURAL COMPLICATION 181
557 PULMONARY HAEMORRHAGE 181
558 TUBERCULOSIS 181
559 EAR PAIN 180
560 COAGULOPATHY 179
561 PNEUMOTHORAX 179
562 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 179
563 INTRAOCULAR PRESSURE INCREASED 178
564 VITREOUS FLOATERS 178
565 PERICARDITIS 177
566 TYPE 2 DIABETES MELLITUS 177
567 DRUG LEVEL DECREASED 176
568 HYPERCHOLESTEROLAEMIA 176
569 ORAL CANDIDIASIS 174
570 RHEUMATOID FACTOR POSITIVE 174
571 VIRAEMIA 174
572 BREAST CANCER 172
573 ENCEPHALITIS 172
574 MELAENA 172
575 MENTAL STATUS CHANGES 172
576 TENOSYNOVITIS 172
577 BODY TEMPERATURE INCREASED 170
578 PRODUCT ODOUR ABNORMAL 170
579 CYTOMEGALOVIRUS TEST POSITIVE 169
580 HEART RATE DECREASED 169
581 IMPAIRED GASTRIC EMPTYING 169
582 INTESTINAL OBSTRUCTION 169
583 LEUKOENCEPHALOPATHY 169
584 MUSCULOSKELETAL DISORDER 169
585 TONGUE DISORDER 169
586 MUCORMYCOSIS 168
587 PNEUMONIA ASPIRATION 168
588 SCLERAL HYPERAEMIA 168
589 CHRONIC ALLOGRAFT NEPHROPATHY 167
590 HAEMATOMA 167
591 HAND DEFORMITY 167
592 INSTILLATION SITE IRRITATION 167
593 ENTHESOPATHY 165
594 HYPERLIPIDAEMIA 165
595 IMMUNE SYSTEM DISORDER 165
596 INTENTIONAL DOSE OMISSION 165
597 OLIGURIA 165
598 PATHOGEN RESISTANCE 165
599 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 164
600 GASTRIC ULCER 164
601 PULMONARY ALVEOLAR HAEMORRHAGE 164
602 SKIN IRRITATION 164
603 INJECTION SITE HAEMORRHAGE 163
604 BLOOD PRESSURE ABNORMAL 162
605 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 162
606 DRUG TOXICITY 162
607 HYPOACUSIS 162
608 IMMUNODEFICIENCY 162
609 JOINT STIFFNESS 162
610 LOW BIRTH WEIGHT BABY 162
611 PNEUMONIA VIRAL 162
612 ROAD TRAFFIC ACCIDENT 162
613 CYTOMEGALOVIRUS CHORIORETINITIS 161
614 PAIN IN JAW 161
615 SINUS DISORDER 161
616 VASCULITIS 161
617 ALANINE AMINOTRANSFERASE ABNORMAL 160
618 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 160
619 EPILEPSY 159
620 FEEDING DISORDER 159
621 NEPHROPATHY 159
622 STEM CELL TRANSPLANT 159
623 SUPERFICIAL INJURY OF EYE 159
624 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 158
625 HEPATITIS B 158
626 LIMB INJURY 158
627 PRESCRIBED UNDERDOSE 158
628 WRONG TECHNIQUE IN DRUG USAGE PROCESS 158
629 IRRITABILITY 157
630 KIDNEY FIBROSIS 157
631 NOCARDIOSIS 157
632 NEURALGIA 156
633 PNEUMOCYSTIS JIROVECI PNEUMONIA 156
634 POLYOMAVIRUS VIRAEMIA 156
635 SWOLLEN TONGUE 156
636 ACUTE MYOCARDIAL INFARCTION 155
637 KAPOSI^S SARCOMA 155
638 MEDICATION ERROR 155
639 PSEUDOMONAL SEPSIS 155
640 SCIATICA 155
641 STILL^S DISEASE 155
642 UROSEPSIS 155
643 DEMYELINATION 154
644 DEVICE ISSUE 154
645 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 154
646 CORONARY ARTERY DISEASE 153
647 GLOSSODYNIA 153
648 HEMIPARESIS 153
649 PNEUMATOSIS INTESTINALIS 153
650 THERAPEUTIC RESPONSE SHORTENED 153
651 UPPER LIMB FRACTURE 153
652 RECTAL HAEMORRHAGE 152
653 ANOREXIA 151
654 PROTEIN URINE PRESENT 151
655 DRUG EFFECT DECREASED 150
656 GASTROENTERITIS VIRAL 150
657 FOOT DEFORMITY 149
658 HEPATOMEGALY 149
659 LUPUS NEPHRITIS 149
660 THROMBOTIC THROMBOCYTOPENIC PURPURA 149
661 EYELID PTOSIS 148
662 SKIN HAEMORRHAGE 148
663 VARICELLA ZOSTER VIRUS INFECTION 148
664 BLOOD TRIGLYCERIDES INCREASED 147
665 PUSTULAR PSORIASIS 147
666 HYDRONEPHROSIS 146
667 PREMATURE DELIVERY 146
668 RENAL INJURY 146
669 ACCIDENTAL OVERDOSE 145
670 BRONCHIECTASIS 145
671 DELIRIUM 145
672 LYMPHOCYTE COUNT DECREASED 145
673 MYASTHENIA GRAVIS 145
674 CHROMATURIA 144
675 SLEEP APNOEA SYNDROME 144
676 INJECTION SITE PRURITUS 143
677 LUNG NEOPLASM MALIGNANT 143
678 PRODUCT SUBSTITUTION ISSUE 143
679 BLOOD ALBUMIN DECREASED 142
680 DRUG TOLERANCE 142
681 GINGIVAL BLEEDING 142
682 HAEMORRHOIDS 142
683 RASH PAPULAR 142
684 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 142
685 IMMUNE THROMBOCYTOPENIA 141
686 QUALITY OF LIFE DECREASED 141
687 HYPOGLYCAEMIA 140
688 LYMPHOCELE 140
689 STEVENS-JOHNSON SYNDROME 140
690 HAEMOLYTIC URAEMIC SYNDROME 139
691 MADAROSIS 139
692 URINARY INCONTINENCE 139
693 ANGINA PECTORIS 138
694 ANKYLOSING SPONDYLITIS 138
695 HELICOBACTER INFECTION 138
696 INTRACRANIAL PRESSURE INCREASED 138
697 PULMONARY CONGESTION 137
698 GRAND MAL CONVULSION 136
699 HERPES VIRUS INFECTION 136
700 JC VIRUS INFECTION 136
701 SCLERODERMA 136
702 CANDIDIASIS 135
703 CARDIO-RESPIRATORY ARREST 135
704 CONCOMITANT DISEASE AGGRAVATED 135
705 EYE HAEMORRHAGE 135
706 GRANULOMA 135
707 MOVEMENT DISORDER 135
708 PRODUCT AVAILABILITY ISSUE 135
709 LEUKAEMIA RECURRENT 134
710 PULMONARY MASS 134
711 RHINOVIRUS INFECTION 134
712 SYSTEMIC CANDIDA 134
713 HIP FRACTURE 133
714 JOINT RANGE OF MOTION DECREASED 133
715 SEASONAL ALLERGY 133
716 SKIN MASS 133
717 BLOOD POTASSIUM DECREASED 132
718 MALNUTRITION 132
719 SCAR 132
720 AUTOIMMUNE HAEMOLYTIC ANAEMIA 131
721 EYELID MARGIN CRUSTING 131
722 PETECHIAE 131
723 TOOTH DISORDER 131
724 ENCEPHALITIS CYTOMEGALOVIRUS 130
725 SCRATCH 130
726 ABORTION SPONTANEOUS 129
727 BLOOD SODIUM DECREASED 129
728 GASTROINTESTINAL INFECTION 129
729 CRYING 128
730 DRUG EFFECT INCOMPLETE 128
731 KIDNEY INFECTION 128
732 PRODUCT PACKAGING ISSUE 128
733 BLEPHARITIS 127
734 HYPERTENSIVE CRISIS 127
735 PHARYNGITIS 127
736 PLASMA CELL MYELOMA 127
737 TRANSIENT ISCHAEMIC ATTACK 126
738 URINARY RETENTION 126
739 RESPIRATORY SYNCYTIAL VIRUS INFECTION 125
740 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 125
741 CARDIOMEGALY 124
742 CIRCULATORY COLLAPSE 124
743 ENCEPHALITIS VIRAL 124
744 MASS 124
745 OBESITY 124
746 STREPTOCOCCAL INFECTION 124
747 AUTOIMMUNE DISORDER 123
748 BRAIN FOG 123
749 ESCHERICHIA SEPSIS 123
750 IRRITABLE BOWEL SYNDROME 123
751 ORAL DISORDER 123
752 PARVOVIRUS B19 INFECTION 123
753 SECRETION DISCHARGE 123
754 BLOOD URIC ACID INCREASED 122
755 FACE OEDEMA 122
756 NO THERAPEUTIC RESPONSE 122
757 DRUG DEPENDENCE 121
758 HERNIA 121
759 INTERVERTEBRAL DISC PROTRUSION 121
760 NODULE 121
761 SKIN HYPERPIGMENTATION 121
762 CUSHING^S SYNDROME 120
763 ILEUS 120
764 MACULAR DEGENERATION 120
765 MYOCLONUS 120
766 MYOSITIS 120
767 RIB FRACTURE 120
768 ENDOCARDITIS 119
769 ENTEROBACTER INFECTION 119
770 GROWTH RETARDATION 119
771 MUSCULOSKELETAL DISCOMFORT 119
772 PERIORBITAL SWELLING 119
773 PRODUCT COMPLAINT 119
774 RENAL TRANSPLANT 119
775 CEREBRAL TOXOPLASMOSIS 118
776 DYSSTASIA 118
777 ESCHERICHIA URINARY TRACT INFECTION 118
778 PRODUCT DISPENSING ERROR 118
779 SINUS CONGESTION 118
780 BRAIN ABSCESS 117
781 CHOLECYSTITIS 117
782 CYSTITIS VIRAL 117
783 ELECTROLYTE IMBALANCE 117
784 HEAD INJURY 117
785 LIQUID PRODUCT PHYSICAL ISSUE 117
786 PANIC ATTACK 117
787 PIGMENTATION DISORDER 117
788 WOUND INFECTION 117
789 CARDIOVASCULAR DISORDER 116
790 EYELIDS PRURITUS 116
791 FLUID OVERLOAD 116
792 GUILLAIN-BARRE SYNDROME 116
793 PEMPHIGUS 116
794 CONCOMITANT DISEASE PROGRESSION 115
795 HAEMODYNAMIC INSTABILITY 115
796 HAIR GROWTH ABNORMAL 115
797 HYPOPHAGIA 115
798 PAPULE 115
799 SHOCK HAEMORRHAGIC 115
800 CHOLANGITIS 114
801 NECROSIS 114
802 PSYCHOTIC DISORDER 114
803 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 113
804 HAEMATEMESIS 113
805 POOR QUALITY PRODUCT ADMINISTERED 113
806 RETINAL DETACHMENT 113
807 HYPERTRANSAMINASAEMIA 112
808 TASTE DISORDER 112
809 CARPAL TUNNEL SYNDROME 111
810 FEAR OF INJECTION 111
811 HEPATOCELLULAR INJURY 111
812 PULMONARY TUBERCULOSIS 111
813 EAR DISCOMFORT 110
814 HAEMATOTOXICITY 110
815 HYPERURICAEMIA 110
816 LARYNGITIS 110
817 TACHYPNOEA 110
818 ACUTE HEPATIC FAILURE 109
819 ATELECTASIS 109
820 DEVICE MALFUNCTION 109
821 FEELING COLD 109
822 GALLBLADDER DISORDER 109
823 KAPOSI'S SARCOMA 109
824 SOFT TISSUE DISORDER 109
825 URINE ABNORMALITY 109
826 ADRENAL INSUFFICIENCY 108
827 CENTRAL NERVOUS SYSTEM LESION 108
828 DIARRHOEA HAEMORRHAGIC 108
829 EATING DISORDER 108
830 HEPATIC CYTOLYSIS 108
831 MULTIPLE ALLERGIES 108
832 DYSKINESIA 107
833 POLYNEUROPATHY 107
834 PRE-EXISTING CONDITION IMPROVED 107
835 RED BLOOD CELL SEDIMENTATION RATE 107
836 SMOOTH MUSCLE CELL NEOPLASM 107
837 DERMATITIS CONTACT 106
838 FULL BLOOD COUNT DECREASED 106
839 SCAB 106
840 SPINAL FRACTURE 106
841 ACTINIC KERATOSIS 105
842 AUTOIMMUNE HEPATITIS 105
843 FAECES DISCOLOURED 105
844 HYPERTRICHOSIS 105
845 VITAMIN D DEFICIENCY 105
846 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 104
847 GLOMERULONEPHRITIS 104
848 THROAT TIGHTNESS 104
849 TOOTHACHE 104
850 ABDOMINAL PAIN LOWER 103
851 BLOOD CREATINE INCREASED 103
852 EOSINOPHILIA 103
853 MUSCLE TWITCHING 103
854 OESOPHAGITIS 103
855 STENOTROPHOMONAS INFECTION 103
856 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 103
857 DERMATITIS EXFOLIATIVE GENERALISED 102
858 FACIAL PAIN 102
859 FOETAL GROWTH RESTRICTION 102
860 FOOT FRACTURE 102
861 FREQUENT BOWEL MOVEMENTS 102
862 RENAL TUBULAR ATROPHY 102
863 SENSORY DISTURBANCE 102
864 SUBARACHNOID HAEMORRHAGE 102
865 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 101
866 AGEUSIA 101
867 ANAPHYLACTIC SHOCK 101
868 CAESAREAN SECTION 101
869 HALLUCINATION, VISUAL 101
870 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 101
871 KNEE ARTHROPLASTY 101
872 STATUS EPILEPTICUS 101
873 BLOOD MAGNESIUM DECREASED 100
874 DEMENTIA 100
875 DYSLIPIDAEMIA 100
876 FRACTURE 100
877 HYPOCALCAEMIA 100
878 ORGANISING PNEUMONIA 100
879 PALLOR 100
880 SYSTEMIC MYCOSIS 100
881 BREATH SOUNDS ABNORMAL 99
882 DUODENAL ULCER PERFORATION 99
883 GRAFT DYSFUNCTION 99
884 HEPATIC FIBROSIS 99
885 POOR QUALITY SLEEP 99
886 ROTATOR CUFF SYNDROME 99
887 ACUTE PULMONARY OEDEMA 98
888 B-CELL LYMPHOMA 98
889 BLOOD IRON ABNORMAL 98
890 EJECTION FRACTION DECREASED 98
891 FEMUR FRACTURE 98
892 HIRSUTISM 98
893 JOINT EFFUSION 98
894 MITRAL VALVE INCOMPETENCE 98
895 PURPURA 98
896 DISSEMINATED ASPERGILLOSIS 97
897 LYMPHOID TISSUE HYPOPLASIA 97
898 PNEUMOMEDIASTINUM 97
899 SERUM SICKNESS 97
900 TOXIC ENCEPHALOPATHY 97
901 ANKLE FRACTURE 96
902 CACHEXIA 96
903 CATARACT OPERATION 96
904 HEPATIC ENCEPHALOPATHY 96
905 HIP ARTHROPLASTY 96
906 HYPERSOMNIA 96
907 RASH GENERALISED 96
908 RESTLESSNESS 96
909 THYMUS HYPOPLASIA 96
910 ATAXIA 95
911 BLOOD URINE PRESENT 95
912 CARDIOMYOPATHY 95
913 ENGRAFTMENT SYNDROME 95
914 LUNG TRANSPLANT REJECTION 95
915 OESOPHAGEAL CANDIDIASIS 95
916 PNEUMONIA KLEBSIELLA 95
917 APHTHOUS ULCER 94
918 APLASIA 94
919 CARDIOGENIC SHOCK 94
920 EYE MOVEMENT DISORDER 94
921 GENERALISED TONIC-CLONIC SEIZURE 94
922 HORDEOLUM 94
923 INTERNATIONAL NORMALISED RATIO INCREASED 94
924 MYOCARDITIS 94
925 NEUROLOGICAL SYMPTOM 94
926 SKIN PAPILLOMA 94
927 AZOTAEMIA 93
928 BLOOD PRESSURE DIASTOLIC INCREASED 93
929 ENTEROCOLITIS 93
930 HEART RATE IRREGULAR 93
931 HYPOMAGNESAEMIA 93
932 IMPAIRED QUALITY OF LIFE 93
933 KERATITIS 93
934 RASH PUSTULAR 93
935 TOOTH INFECTION 93
936 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 92
937 COLON CANCER 92
938 DISABILITY 92
939 PRODUCT ADMINISTRATION INTERRUPTED 92
940 RENAL TUBULAR INJURY 92
941 BLOOD GLUCOSE DECREASED 91
942 EXTRA DOSE ADMINISTERED 91
943 GLUCOSE TOLERANCE IMPAIRED 91
944 HEPATITIS CHOLESTATIC 91
945 HEPATOSPLENOMEGALY 91
946 MALABSORPTION 91
947 RETCHING 91
948 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 90
949 EYELID DISORDER 90
950 SKIN REACTION 90
951 CORNEAL ABRASION 89
952 DRUG ADMINISTRATION ERROR 89
953 HEPATIC ENZYME ABNORMAL 89
954 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 89
955 RESPIRATORY TRACT CONGESTION 89
956 ABASIA 88
957 NEOPLASM PROGRESSION 88
958 PAPILLOEDEMA 88
959 PARAESTHESIA ORAL 88
960 PRESYNCOPE 88
961 RENAL TUBULAR DISORDER 88
962 VAGINAL HAEMORRHAGE 88
963 ABNORMAL BEHAVIOUR 87
964 BLOOD PRESSURE DIASTOLIC DECREASED 87
965 CAPILLARY LEAK SYNDROME 87
966 JOINT DISLOCATION 87
967 LIVER TRANSPLANT 87
968 METASTASES TO LUNG 87
969 PLATELET COUNT ABNORMAL 87
970 RENAL CYST 87
971 STEROID DEPENDENCE 87
972 TOXOPLASMOSIS 87
973 UPPER-AIRWAY COUGH SYNDROME 87
974 ARTHROPOD BITE 86
975 BONE DISORDER 86
976 BONE MARROW TRANSPLANT 86
977 CYTOKINE RELEASE SYNDROME 86
978 DECREASED IMMUNE RESPONSIVENESS 86
979 HEAD DISCOMFORT 86
980 MULTIPLE SCLEROSIS 86
981 ORAL DISCOMFORT 86
982 PHOTOPSIA 86
983 RALES 86
984 RAYNAUD^S PHENOMENON 86
985 ACIDOSIS 85
986 APHONIA 85
987 CYST 85
988 LARGE INTESTINE PERFORATION 85
989 NIGHTMARE 85
990 RENAL CELL CARCINOMA 85
991 TRANSFUSION 85
992 VITAMIN D DECREASED 85
993 BLINDNESS UNILATERAL 84
994 BONE EROSION 84
995 CYTOMEGALOVIRUS ANTIGEN POSITIVE 84
996 ERYTHRODERMIC PSORIASIS 84
997 POLYARTHRITIS 84
998 RETINAL HAEMORRHAGE 84
999 SECONDARY IMMUNODEFICIENCY 84